Skip to main content

Advertisement

SpringerLink
Log in

Community pharmacist intervention in patients with renal impairment

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background In France, community pharmacists do not have free access to patients’ lab results, and it is therefore impossible for them to identify patients with renal impairment. Objective (1) to evaluate the ability of community pharmacists (CPs) to identify drug related problems (DRP) in patients at risk for or suffering from renal impairment; (2) to evaluate the proportions of recommendations by CPs that lead to a modification by GP. Setting A prospective and observational study involving 24 community pharmacists in France. Methods Following special training, community pharmacists were asked to select 52 patients with the following characteristics: ≥65 years of age; prescribed at least two diabetic and/or antihypertensive drugs. Serum creatinine value was obtained for each patient and glomerular filtration rate estimated (eGFR) with the aMDRD formula. Those with a eGFR 60 ml/min/1.73 m² were considered having chronic kidney disease (CKD). Data was collected concerning whether the community pharmacists identified drug related problems and tried to inform the GP who prescribed the medications. Identified DRP were reviewed by a team of nephrologists and hospital clinical pharmacists. Primary outcome The proportion of CKD patients and those without serum creatinine monitoring, the number of drug related problems identified by community pharmacists, and the proportion of drug related problems resolved by the community pharmacists intervention to the GP. Results Of the total 791 patients identified, 180 (22.8 %) exhibited CKD, and 57 (7.2 %) had not undergone serum creatinine monitoring. Among the 1297 drugs prescribed, 260 had to be adapted to eGFR. The proportion of DRP was 21.5 % (56/260), of which 40 % (20) were identified by community pharmacists. Once the GP was informed, 33.3 % (6/18) of DRP were resolved. Conclusion Community pharmacists identified 40 % of DRP related to CKD prescriptions, leading to prescription modification by GPs in a third of the cases. These interventions are likely to decrease drug-related morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. HAS December 2011. Evaluation du débit de filtration glomérulaire et du dosage de la créatininémie dans le diagnostic de la maladie rénale chronique chez l’adulte [Glomerular filtration rate evaluation and serum creatinine in the diagnosis of chronic kidney disease in adults]. ISBN: 978-2-11-128508-8. http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-12/rapport_dfg_creatininemie.pdf. Accessed 14 Feb 2014.

  2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.

    Article  CAS  PubMed  Google Scholar 

  3. HAS février 2012 guide du parcours de soins. Maladie Rénale Chronique de l’adulte [Internet]. ISBN: 978-11-128521-7. http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-4/guide_parcours_de_soins_mrc_web.pdf. Accessed 14 Feb 2014.

  4. Cogneau J, Blanchecotte F, Halimi J. BIRD: base de données sur la fonction rénale en région Centre [BIRD: database on renal function in the Centre Region]. Ann Biol Clin. 2008;66(3):285–90.

    CAS  Google Scholar 

  5. Stengel B, Couchoud C, Helmer C, Loos-Ayav C. Épidémiologie de l’insuffisance rénale chronique en France [Epidemiology of chronic renal failure in France]. Presse Med. 2007;36(12):1811–21.

    Article  PubMed  Google Scholar 

  6. Bouattar T, Benasila S, Mattous M, Ezzaitouni F, Ouzeddoun N, Rhou H, et al. L’atteinte rénale chez le diabétique âgé [Renal disease in elderly diabetic]. NPG. 2010;10(55):43–9.

    Google Scholar 

  7. Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;65(8):757–73.

    Article  CAS  PubMed  Google Scholar 

  8. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother. 2004;38(5):853–8.

    Article  PubMed  Google Scholar 

  9. Pourrat X, Sipert AS, Sautenet B, Merieau E, Grassin J, Halimi JM. Drugs adjustment dosage at hospital discharge for patients with renal failure: study of 326 medical records. Presse Med. 2012;41(4):e189–94.

    Article  PubMed  Google Scholar 

  10. Nash Kevin, Hafeez Abdul, Hou Susan. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–6.

    Article  PubMed  Google Scholar 

  11. Rapport de l’Académie nationale de Pharmacie: Bonnes pratiques de dispensation du médicament par le pharmacien d’officine [Report of the National Academy of Pharmacy: Good practices for drug dispensing by the pharmacist]. http://www.acadpharm.org/dos_public/Rapport_Bonnes_pratiques_de_dispensation__adoptEpar_le_Conseil_du_27_11_2013_VF.pdf. Accessed 22 Feb 2015.

  12. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.

    Article  CAS  PubMed  Google Scholar 

  13. Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother. 2009;43(10):1598–605.

    Article  PubMed  Google Scholar 

  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.

    Article  CAS  PubMed  Google Scholar 

  15. National Kidney Foundation. Guidelines and commentaries. https://www.kidney.org/professionals/guidelines/guidelines_commentaries. Accessed 07 Jul 2015.

  16. Prat L, Caille A, Sautenet B, Merieau E, Leger J, Giraudeau B, et al. L’insuffisance rénale en milieu hospitalier: est-ce fréquent? Est-ce grave? Chez qui? Etude Néphrovigilance [Renal failure in hospital: is it common? Is it serious? For whom? Nephrovigilance study]. Soc Néphrol Brux Ther. 2010;5(6):462–468.

    Google Scholar 

  17. Blicklé JF, Doucet J, Krummel T, Hannedouche T. Diabetic nephropathy in the elderly. Diabetes Metab. 2007;33:S40–55.

    Article  PubMed  Google Scholar 

  18. Pozuelos Estrada G, Molina Martínez L, Romero Perera JJ, Díaz Herrera N, Cañón Barroso L, Buitrago Ramírez F. Prevalence of hidden renal failure calculated through formulas on the degree of renal function in hypertense patients over 60 referred to out-patients for blood pressure monitoring. Aten Prim. 2007;39(5):247–53.

    Article  Google Scholar 

  19. Chanard J. Insuffisance rénale chronique et hypertension en pratique cardiologique de ville [Chronic renal failure and hypertension in community, experience of cardiology practice]. Presse Med. 2001;30(26):1288–94.

    CAS  PubMed  Google Scholar 

  20. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockcroft–Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–73.

    Article  PubMed  Google Scholar 

  21. Via-Sosa MA, Lopes N, March M. Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment—a comparative study. BMC Fam Pract. 2013;14:96.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Lefèvre T. Analyse des interventions pharmaceutiques réalisées lors de la validation des prescriptions médicales, au sein d’une officine de pharmacie [Analysis of pharmaceutical interventions during the review of medical prescriptions in a community pharmacy]. J Pharm Clin. 2011;30(3):155–8.

    Google Scholar 

  23. Bryant LJM, Coster G, Gamble GD, McCormick RN. The General Practitioner–Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract. 2011;19(2):94–105.

    Article  PubMed  Google Scholar 

  24. Schlecht-Bauer D, Sautenet B, Emonet M, Hay N, Guegan F, Rosset P, et al. Insuffisance rénale et médicaments: suivis patients coordonnés entre pharmaciens officinaux et hospitaliers [Renal impairment and drugs: coordination between community pharmacists and hospital pharmacists]. Pharm Hosp Clin. 2012;47(2):123–6.

    Google Scholar 

  25. Rubio-Valera M, Jové AM, Hughes CM, Guillen-Solà M, Rovira M, Fernández A. Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study. BMC Health Serv Res. 2012;7(12):188.

    Article  Google Scholar 

Download references

Funding

The study had been financed by the URPS Pharmacists of Center region.

Conflicts of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Pharmacy Department, Hôpital Trousseau, CHU de Tours, 2 bd Tonnellé, 37044, Tours Cedex, France

    Xavier Pourrat & Anne-Sophie Sipert

  2. Nephrology Department, Tours University Hospital, Tours Cedex, France

    Philippe Gatault, Bénédicte Sautenet & Jean-Michel Halimi

  3. Pharmacy Hay-Moire, Vernou sur Brenne, France

    Nicolas Hay

  4. URPS Medical Biologists, Région Centre, Bourges, France

    Francis Guinard

  5. URPS Pharmacists, Région Centre, Huisseau sur cosson, France

    Françoise Guegan

Authors
  1. Xavier Pourrat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne-Sophie Sipert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Gatault
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bénédicte Sautenet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicolas Hay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francis Guinard
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Françoise Guegan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-Michel Halimi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier Pourrat.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pourrat, X., Sipert, AS., Gatault, P. et al. Community pharmacist intervention in patients with renal impairment. Int J Clin Pharm 37, 1172–1179 (2015). https://doi.org/10.1007/s11096-015-0182-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-015-0182-4

Keywords

Search

Navigation